Clinical Trial Detail

NCT ID NCT02305563
Title An Investigational Immuno-therapy Study of Ulocuplumab in Combination With Low Dose Cytarabine in Patients With Newly Diagnosed Acute Myeloid Leukemia
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

acute myeloid leukemia

Therapies

Cytarabine + Ulocuplumab

Age Groups: adult senior

No variant requirements are available.